Recap: Cytek Biosciences Q1 Earnings - Cytek Biosciences (NASDAQ:CTKB)

Cytek Biosciences CTKB reported its Q1 earnings results on Tuesday, May 9, 2023 at 04:03 PM.

Here's what investors need to know about the announcement.

Cytek Biosciences missed estimated earnings by 100.0%, reporting an EPS of $0.0 versus an estimate of $0.03.

Revenue was up $2.02 million from the same period last year.

Last quarter the company beat on EPS by $0.01 which was followed by a 7.86% drop in the share price the next day.

Here's a look at Cytek Biosciences's past performance:

Quarter	Q4 2022	Q3 2022	Q2 2022	Q1 2022
EPS Estimate	0.05	0.02	0.02	0
EPS Actual	0.06	0.04	0.03	0.01
Revenue Estimate	50.22M	43.29M	39.63M	32.51M
Revenue Actual	48.34M	40.48M	40.16M	35.06M

To track all earnings releases for Cytek Biosciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.